2 days ago · Measurable residual disease (MRD) monitoring has become a critical component in the management of acute myeloid leukemia (AML), to inform prognosis, guide

Jul 15, 2020 · Minimal residual disease (MRD) is common in patients with blood cancers, such as leukemia, lymphoma and multiple myeloma. But what does this mean for patients and their …

5 days ago · CURE spoke with Dr. Dickran Kazandjian about why MRD matters for patients with multiple myeloma. During the 2025 American Society of Hematology annual meeting, held …

Minimal residual disease (MRD), also known as molecular residual disease, or measurable residual disease, is the medical condition in which small number of cancer cells persist in a …

Aug 13, 2025 · Minimal Residual Disease (MRD), also called measurable residual disease, refers to the small population of malignant cells that remain after treatment and are undetectable by …

1 day ago · Minimal residual disease is “a credible intermediate endpoint” for some patients with newly diagnosed acute myeloid leukemia, researchers report.

This persistence of microscopic cancer cells is known as residual disease, and is often referred to as Minimal Residual Disease (MRD), particularly in blood cancers like leukemia and lymphoma.

Minimal (or measurable) residual disease (MRD) findings have been shown in numerous studies to correlate strongly with clinical outcomes in the posttherapy setting.

Jul 1, 2025 · Learn how physicians use this crucial tool in modern oncology to improve patient outcomes. Minimal residual disease (MRD) testing is a critical tool for assessing the long-term …

Nov 20, 2024 · Measurable or minimal residual disease (MRD) testing is used to see if the cancer treatment is working and to guide further treatment plans. MRD testing is mainly used in blood …